JERUSALEM (Reuters) - Israel’s Medivie Therapeutic said on Sunday it signed a $110 million deal to grow and export medical cannabis to an international financial investor over a four year period.
The deal is dependent on Israel allowing export of medical cannabis, a decision the company said it expects to come in the near future. It did not identify the buyer.
Medivie said in a statement to the Tel Aviv Stock Exchange that it would grow the cannabis on 25 acres (10 hectares) either in Israel or a different country.
